- Investing | February 05, 2014
Valeant's Inorganic Growth Could Threaten These 3 Companies in 2014
Valeant just made its first acquisition of the year. Let’s take a closer look at three companies -- Allergan, Actavis, and Zeltiq -- which could be threatened by the company’s inorganic growth.
- Investing | November 03, 2013
Is Abbott Labs Destined for Greatness?
Let's see what the numbers say about Abbott (ABT).
- Investing | October 23, 2013
Amarin, Cubist Pharmaceuticals, and Abaxis Could Be Big Movers Today
Keep an eye on Amarin, Cubist, and Abaxis -- they could make big moves during today's trading.
- Investing | August 16, 2013
The Collapse of Coal
A confluence of factors is killing off coal plants one by one.
- Investing | June 12, 2013
What Do Dividend Stocks, Coal, and Cameroon Have in Common?
The Tony Awards of utilities have been announced.
- Investing | April 24, 2013
This Dividend Stock Just Pushed up Its Payout
Can this utility electrify your earnings?
- Investing | February 23, 2013
Ameren Earnings: 1 Dividend That's Here to Stay
The utility opts for regulation over generation.
- Investing | February 04, 2013
Why Repros Is Poised to Keep Plunging
Market-lagging returns could be written in this 1-Star.
- Investing | January 04, 2013
Does This Pharma Have Spinout Envy?
While other big pharmas are spinning out businesses, Merck stays on course.
- Investing | January 03, 2013
Will These Risks Crush Questcor in 2013?
What are the biggest overhangs facing this biotech company?